SCHEMBL578059

SCHEMBL578059

CCCCCCCCCCCCCCCCCCOCC(O)CN(C)C

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.67
HTT P42858 2/20 0.65
SPHK1 Q9NYA1 1/20 0.59
LPAR5 Q9H1C0 4/20 0.56
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 1/20 0.44
THRB P10828 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 1/20 0.44
LPAR1 Q92633 7/20 0.44
LPAR3 Q9UBY5 7/20 0.44
LPAR2 Q9HBW0 4/20 0.44
LPAR6 P43657 3/20 0.44
LPAR4 Q99677 3/20 0.44
PLA2G2C Q5R387 2/20 0.43
HSD17B10 Q99714 1/20 0.42
CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968392 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL2988607 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL8454480 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL2994684 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL12802300 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL2981072 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL3964904 1.00 USP2 (0.67) USP2HTTSPHK1LPAR5CYP1A2
Bromide SCHEMBL2229414 0.98 USP2 (0.65) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL258455 0.92 USP2 (0.55) USP2HTTSPHK1LPAR5CYP1A2
SCHEMBL14339072 0.90 USP2 (0.56) USP2HTTSPHK1LPAR5LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2404592-B1 HAIR TREATMENT COMPOSITION SHISEIDO CO LTD (JP) 2018-07-18 EP claimed
US-8273336-B2 Hair treatment composition SHISEIDO COMPANY, LTD. (JP) 2012-09-25 US claimed
US-20120070398-A1 Hair Cosmetic SHISEIDO COMPANY, LTD. (JP) 2012-03-22 US claimed
US-20120052032-A1 HAIR TREATMENT COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2012-03-01 US claimed
EP-2417963-A1 HAIR COSMETIC Shiseido Company, Ltd. (JP) 2012-02-15 EP claimed
EP-2404592-A1 HAIR TREATMENT COMPOSITION Shiseido Company, Ltd. (JP) 2012-01-11 EP claimed
US-20100168450-A1 NOVEL BRANCHED ALKOXYLATES THOEN JOHAN A 2010-07-01 US claimed
EP-2152652-A1 NOVEL ALKYLOXY-ETHERS AND ALKOXYLATES THEREOF Dow Global Technologies Inc. (US) 2010-02-17 EP claimed
EP-2139833-A1 NOVEL BRANCHED ALKOXYLATES Dow Global Technologies Inc. (US) 2010-01-06 EP claimed
WO-2008134390-A1 NOVEL BRANCHED ALKOXYLATES DOW GLOBAL TECHNOLOGIES INC. (US) 2008-11-06 WO claimed
WO-2008134387-A1 NOVEL ALKYLOXY-ETHERS AND ALKOXYLATES THEREOF DOW GLOBAL TECHNOLOGIES INC. (US) 2008-11-06 WO claimed
US-20260045593-A1 THERMAL INSULATING MATERIAL NITTO DENKO CORPORATION (JP) 2026-02-12 US disclosed
WO-2025070432-A1 HEAT INSULATING MATERIAL 日東電工株式会社 2025-04-03 WO disclosed
WO-2024038843-A1 THERMAL INSULATION MATERIAL 日東電工株式会社 2024-02-22 WO disclosed
EP-2404592-B1 HAIR TREATMENT COMPOSITION SHISEIDO CO LTD (JP) 2018-07-18 EP disclosed
US-20020004605-A1 Method of synthesizing glycidyl ether compounds in the absence of water and organic solvents KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 2002-01-10 US disclosed
EP-0255126-B1 2-ACYLOXYPROPYLAMINE DERIVATIVES, METHOD FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1992-10-14 EP disclosed
US-4855489-A PROTEIN KINASE C INHIBITORS GOEDECKE AKTIENGESELLSCHAFT (DE) 1989-08-08 US disclosed
EP-0279458-A1 2-Propyl amine derivatives, processes for their preparation and their use GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-08-24 EP disclosed
EP-0255126-A2 2-Acyloxypropylamine derivatives, method for their preparation and medicaments containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052032-A1 HAIR TREATMENT COMPOSITION POLR1C, SHH, DNMT1 USP2 4199/4885HTT 608/4885SPHK1 776/4885
US-20260045593-A1 THERMAL INSULATING MATERIAL ARID2, BET1, H1-4 USP2 3965/4885HTT 1631/4885SPHK1 2464/4885
US-20020004605-A1 Method of synthesizing glycidyl ether compounds in the absence of water and organic solvents TET2, DGAT1, ALKBH3 USP2 3857/4885HTT 1505/4885SPHK1 1328/4885
US-20120070398-A1 Hair Cosmetic H1-0, H1-4, HRH4 USP2 3997/4885HTT 334/4885SPHK1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.